Business
Britain goes on COVID-19 vaccine spending spree – The Australian Financial Review
The race is heating up among rich nations eager to get hold of stocks of as-yet unproven vaccines.
The US has booked 300 million of AstraZeneca’s first billion doses, and last week nailed a $US1.95 billion ($2.7 billion) deal with Pfizer for 100 million doses, with an option to secure an additional 500 million doses.
And the European Union is in talks with at least half a dozen developers, including Pfizer, Sanofi and Johnson & Johnson, but Reuters has reported this week that haggling continues over the price, payment method and potential liability costs.
Countries have a duty to protec…
-
General21 hours agoBHP cops $5b value hit on talk of China trade blockade
-
Noosa News19 hours agoDally M Awards 2025 live: Best of the NRL and NRLW honoured in Sydney
-
Noosa News20 hours agoWhale calf freed in tense shark net rescue off Kirra Beach as Sea World and fisheries teams battle rough seas
-
Noosa News18 hours agoDr Marianne Gale appointed new Queensland Chief Health Officer after lengthy search